Cargando…
Preclinical Toxicology of Vaccines
Immunity to targeted infectious diseases may be conferred or enhanced by vaccines, which are manufactured from recombinant forms as well as inactivated or attenuated organisms. These vaccines have to meet requirements for safety, quality, and efficacy. In addition to antigenic components, various ad...
Autores principales: | Green, M.D., Al-Humadi, N.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161388/ http://dx.doi.org/10.1016/B978-0-12-803620-4.00027-X |
Ejemplares similares
-
Preclinical Toxicology of Vaccines
por: Green, Martin David, et al.
Publicado: (2013) -
Preclinical toxicological assessment of levothyroxine and liothyronine Maillard impurities
por: Agarwal, Anju, et al.
Publicado: (2022) -
Editorial: Advances in alternative methods in preclinical pharmacology and toxicology
por: Betti, Andresa Heemann, et al.
Publicado: (2023) -
Types of acute phase reactants and their importance in vaccination
por: Khalil, Rafaat H., et al.
Publicado: (2020) -
Microcystin Toxicokinetics, Molecular Toxicology, and Pathophysiology in Preclinical Rodent Models and Humans
por: Arman, Tarana, et al.
Publicado: (2021)